Will Kaback
speaker
1,313 appearances
13 recordings
1 series
first heard Aug 2026
last heard 5d ago
Will Kaback’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 13 in all, peaking in Sep 2026 with 12.
Appearances
And those are two very different futures.
Now here's what the left is saying.
Many on the left suggest GLP-1s should be treated like any other medicine.
Some lament that Americans' views on weight cause GLP-1 users to feel guilty.
Others worry that these drugs are exacerbating certain eating disorders.
In New York Magazine, Sarah Jones asked, why can't we treat GLP-1s like medicine?
When I first started taking the drug, I was reluctant to mention it to anyone.
Diabetes is complicated enough by itself, and the American healthcare system is one more obstacle to good health.
In my case, Cigna refused to cover Monjaro at the lowest dose, which forced me to increase it on corporate timing, not my own or my own doctor's.
I hoped it would be all right.
The endocrinologist nurse told me that I might have gastrointestinal systems, but the drug was good for my blood sugar and the side effects usually got easier over time.
She was right for a while.
Then my progress seemed to stall.
I lost nearly a third of my total body weight by April and saw a new endocrinologist who told me that I developed a significant vitamin D deficiency.
I told her I wanted to have children, and she finally took me off Manjaro.
I don't know who to blame for any of this.
Perhaps I could blame the Reformation, or capitalism, or some unholy combination thereof.
The damage is the same.
We've lost sight of Manjaro's medicine.
A GLP-1 is not snake oil or a miracle drug, but a tool, and it can be helpful without being right for every person or every situation.
Showing 61–80 of 1,313 · page 4 of 66
← Previous
Next →